132.73
0.12 (0.09%)
| Penutupan Terdahulu | 132.61 |
| Buka | 132.72 |
| Jumlah Dagangan | 5,377,273 |
| Purata Dagangan (3B) | 2,288,203 |
| Modal Pasaran | 9,979,133,952 |
| Harga / Buku (P/B) | 7.94 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 10 Aug 2026 |
| EPS Cair (TTM) | -3.61 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.75% |
| Nisbah Semasa (MRQ) | 15.82 |
| Aliran Tunai Operasi (OCF TTM) | -188.02 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -120.81 M |
| Pulangan Atas Aset (ROA TTM) | -19.65% |
| Pulangan Atas Ekuiti (ROE TTM) | -27.85% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Apogee Therapeutics, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -3.0 |
| Purata Bergerak Teknikal | -5.0 |
| Osilator Teknikal | 4.0 |
| Purata | -1.75 |
|
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 7.62% |
| % Dimiliki oleh Institusi | 137.71% |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| DAMBKOWSKI CARL | - | 132.55 | -26,400 | -3,499,320 |
| HENDERSON MICHAEL THOMAS | - | 132.55 | -80,000 | -10,604,000 |
| Jumlah Keseluruhan Kuantiti Bersih | -106,400 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -14,103,320 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 132.55 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| HENDERSON MICHAEL THOMAS | Pegawai | 22 Jun 2026 | Jual automatik (-) | 80,000 | 132.55 | 10,604,000 |
| DAMBKOWSKI CARL | Pegawai | 22 Jun 2026 | Jual automatik (-) | 26,400 | 132.55 | 3,499,320 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |